ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0036

Molecular Phenotyping of Late-Stage Knee Osteoarthritis Synovium Through Total RNA-Sequencing

Anusha Ratneswaran1, Chiara Pastrello1, Pratibha Potla2, Osvaldo Espin-Garcia2, Starlee Lively2, Anthony Perruccio3, Raj Rampersaud2, Rajiv Gandhi2 and Mohit Kapoor4, 1University Health Network, Toronto, ON, Canada, 2Krembil RI, Toronto, Canada, 3Krembil Research Institute, UHN; University of Toronto, Toronto, ON, Canada, 4Krembil RI, Toronto, ON, Canada

Meeting: ACR Convergence 2020

Keywords: Epigenetics, genomics, Osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Friday, November 6, 2020

Title: Genetics, Genomics & Proteomics Poster

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Knee Osteoarthritis (OA) is a painful, disabling condition and molecular mechanisms underlying this disease are poorly understood. In recent years, OA is increasingly viewed as a disease with differing phenotypes which may contribute to its pathogenesis. Characterizing these phenotypes could play an integral role in the development of appropriate therapies. The synovium is a key driver of pathological changes in OA and to date there are few studies examining total RNA sequencing in synovial tissue.  This study uses total RNA sequencing to profile the synovium of patients with advanced radiographic knee OA, and elucidates whether these patients have differing endogenous molecular phenotypes.

Methods: Total RNA sequencing was performed on synovium samples from 50 end-stage knee OA patients (KL 3/4).  After filtering, 19,857 genes were expressed in synovium. Genes with a mean, and variance greater than 30 across samples were kept for further downstream analysis (4267). To objectively identify number of distinct clusters within the patient cohort, mean silhouette width was plotted, and peaked at 3; indicating this was the optimal cluster number. Genes differentially expressed between clusters were used for pathway analysis. Identified pathways with a q-value less than 0.01 and a gene-ratio higher than 0.05 were retained and annotated to pathways. Interactions among genes were collected using Integrated Integrations Database (University of Toronto), and networks were constructed. Pearson correlation was calculated in each cluster for long-noncoding (lnc) and circular (circ) RNA from differentially expressed genes between clusters. Only correlations with absolute rho greater than 0.95 (lncRNA) or 0.85 (circRNA) were retained and used to construct Protein-Protein Interaction networks.

Results: Unbiased gene clustering indicated 3 clusters of patients distinguished by endogenous molecular differences. These groups do not demonstrate significant differences in measured clinical or anthropometric characteristics including sex, BMI, blood pressure, cholesterol, synovial inflammation, and patient reported pain. The clusters share signaling pathways such as  EGFR1, innate and adaptive immune system. Differentially regulated pathways include: signaling by receptor tyrosine kinase, cytokine signaling, and TCR (cluster 2 vs 1) as well as neutrophil degranulation, skeletal muscle, EMT regulation, apoptosis, membrane trafficking, vesicle mediated transport, toll-like receptor signaling and hemostasis (cluster 3 vs 2). We have identified several lnc and circRNA that interact with genes in each distinct pathway and have defined their associated clusters and their positive or negative gene interactions.

Conclusion: Overall, we have observed that endogenous molecular signatures derived from synovium of end-stage OA patients cluster into 3 groups. Pronounced differences in gene expression between clusters indicate both shared and distinct actively transcribed pathways. Identified lnc and circRNA contribute to unique molecular mechanisms differentially expressed between clusters. These differences in endogenous molecular mechanisms may play a role in heterogenous disease development.


Disclosure: A. Ratneswaran, None; C. Pastrello, None; P. Potla, None; O. Espin-Garcia, None; S. Lively, None; A. Perruccio, None; R. Rampersaud, None; R. Gandhi, None; M. Kapoor, None.

To cite this abstract in AMA style:

Ratneswaran A, Pastrello C, Potla P, Espin-Garcia O, Lively S, Perruccio A, Rampersaud R, Gandhi R, Kapoor M. Molecular Phenotyping of Late-Stage Knee Osteoarthritis Synovium Through Total RNA-Sequencing [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/molecular-phenotyping-of-late-stage-knee-osteoarthritis-synovium-through-total-rna-sequencing/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/molecular-phenotyping-of-late-stage-knee-osteoarthritis-synovium-through-total-rna-sequencing/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology